Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

PURPOSE: To assess the efficacy, safety, and quality-of-life impact of switching adjuvant treatment in hormone receptor-positive primary breast cancer patients who are still premenopausal after 2–3 years of tamoxifen therapy to anastrozole plus goserelin as compared with continuing tamoxifen over a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Li, Jian-wei, Liu, Guang-yu, Ji, Ya-jie, Yan, Xia, Pang, Da, Jiang, Ze-fei, Chen, De-dian, Zhang, Bin, Xu, Bing-he, Shao, Zhi-ming
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312049/
https://ncbi.nlm.nih.gov/pubmed/30643455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183672
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker